The Promise of Infrared Spectroscopy in Liquid Biopsies for Solid Cancer Detection
Open Access
- 4 February 2025
- journal article
- review article
- Published by MDPI AG in Diagnostics
- Vol. 15 (3) , 368
Abstract
Attenuated total reflection-Fourier transform infrared (ATR-FTIR) spectroscopy has shown significant promise in the context of liquid biopsy, offering a potential tool for cancer diagnostics. Unlike traditional tissue biopsies, which may not fully capture the clonal heterogeneity of tumors, liquid biopsy reflects the dynamic state of the disease and its progression more comprehensively. Biofluids such as serum and plasma are low-cost, minimally invasive diagnostic media with well-established clinical uses. This review assesses the use of ATR-FTIR spectroscopy to detect biochemical changes in biofluids linked to various malignancies, including breast, ovarian, endometrial, prostate, bladder, kidney, pancreatic, colorectal, hepatic, esophageal, gastric, lung, and brain cancers. While ATR-FTIR offers the advantages of rapid, minimally invasive detection and real-time disease monitoring, its integration into clinical practice faces challenges, particularly in terms of reproducibility due to variability in sample preparation, spectral acquisition, and data processing. The translation of ATR-FTIR into routine diagnostics will require validation through large-scale cohort studies and multicenter trials to ensure its clinical reliability and effectiveness.Keywords
This publication has 75 references indexed in Scilit:
- Efficacy of blood plasma spectroscopy for early liver cancer diagnostics in obese patientsAnnals of Hepatology, 2024
- Orthogonal Surface‐Enhanced Raman Scattering/Field‐Effect Transistor Detection of Breast and Colorectal Cancer‐Derived Exosomes using Graphene as a Tag‐Free Diagnostic TemplateAdvanced NanoBiomed Research, 2023
- PSA screening—a matter of debate?memo - Magazine of European Medical Oncology, 2019
- Screening for Pancreatic CancerJAMA, 2019
- Recognising Lung Cancer in Primary CareAdvances in Therapy, 2018
- Treatment-related changes in glioblastoma: a review on the controversies in response assessment criteria and the concepts of true progression, pseudoprogression, pseudoresponse and radionecrosisClinical and Translational Oncology, 2017
- Multimodal lung cancer screening using the ITALUNG biomarker panel and low dose computed tomography. Results of the ITALUNG biomarker studyInternational Journal of Cancer, 2017
- Characterization of extracellular vesicles by IR spectroscopy: Fast and simple classification based on amide and C H stretching vibrationsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2017
- AASLD guidelines for the treatment of hepatocellular carcinomaHepatology, 2017
- Segregation of ovarian cancer stage exploiting spectral biomarkers derived from blood plasma or serum analysis: ATR‐FTIR spectroscopy coupled with variable selection methodsBiotechnology Progress, 2015